REFERENCE
FDA.Rituximab (marketed as Rituxan). Internet Document: [3 pages], Dec 2006. Available from: URL: http://www.fda.gov
FDA.Life-threatening brain infection in patients with systemic lupus erythematosus after rituxan (Rituximab) treatment. Internet Document: [2 pages], 18 Dec 2006. Available from: URL: http://www.fda.gov
Rights and permissions
About this article
Cite this article
Rituxan associated with PML, warns US FDA. React. Wkly. 1133, 3 (2007). https://doi.org/10.2165/00128415-200711330-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200711330-00006